Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1a/b Study of ADRX-0706 in Subjects With Select Advanced Solid Tumors

NCT06036121 is registered in ClinicalTrials.gov with Adcentrx Therapeutics as lead sponsor.

NCT NCT06036121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06036121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1a/b Study of ADRX-0706 in Subjects With Select Advanced Solid Tumors
Lead sponsor
Adcentrx Therapeutics
Phase
Phase 1
Overall status
Active, not recruiting
Start date
September 26, 2023
Completion date
December 31, 2026
Enrollment
144 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, solid tumors, triple negative breast cancer (tnbc), urothelial cancer